Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: GENFIT

Market Cap 498M 577M 458M 431M 810M 54.47B 817M 5.43B 2.11B 26.73B 2.17B 2.12B 92.49B P/E 2025
-3.06x
P/E 2026 * 49.9x
Enterprise Value 443M 514M 408M 384M 721M 48.49B 727M 4.83B 1.88B 23.8B 1.93B 1.89B 82.32B EV / Sales 2025
2.34x
EV / Sales 2026 * 4.74x
Free-Float
86.88%
Yield 2025 *
-
Yield 2026 * -
1 day-2.16%
1 week+5.05%
Current month+5.05%
1 month+5.39%
3 months-8.27%
6 months+141.06%
Current year+66.33%
1 week 9.98
Extreme 9.98
10.2
1 month 9.5
Extreme 9.5
10.2
Current year 7.26
Extreme 7.26
11.05
1 year 3.28
Extreme 3.2801
11.05
3 years 2.95
Extreme 2.95
11.05
5 years 2.95
Extreme 2.95
11.05
10 years 0
Extreme 0
36.86
Manager TitleAgeSince
Chief Executive Officer 58 16/09/2019
Director of Finance/CFO 52 22/04/2021
Chief Tech/Sci/R&D Officer - 27/11/2025
Director TitleAgeSince
Chairman 70 16/06/2017
Director/Board Member 54 15/09/1999
Director/Board Member 58 16/06/2017
Change 5-day change 1-year change 3-year change Capi.($)
-2.16%+5.05% - - 548M
-0.22%-0.40%-13.00%-13.09% 43.51B
+0.76%+5.50%+296.71%+540.82% 33.29B
-0.47%-2.05%-0.66%+31.20% 29.34B
-4.74%-8.37%+7.17%-20.99% 29.9B
+0.06%+2.71%+13.31%+21.11% 25.42B
-0.02%+8.40% - - 14.36B
-0.98%-2.08%+51.87%+106.06% 13.18B
-0.29%-3.76%+2.12%+1.69% 12.72B
+1.67%-0.36%+110.87%+81.16% 12.08B
Average -0.66%+0.67%+58.55%+93.50% 23.76B
Weighted average by Cap. -0.69%+0.72%+59.64%+103.58%

Financials

2025 2026 *
Net sales 66.82M 77.45M 61.43M 57.82M 109M 7.31B 110M 728M 283M 3.59B 291M 284M 12.41B 95.2M 110M 87.52M 82.38M 155M 10.41B 156M 1.04B 404M 5.11B 414M 405M 17.68B
Net income -8.3M -9.62M -7.63M -7.18M -13.5M -908M -13.61M -90.46M -35.22M -446M -36.12M -35.35M -1.54B 18.31M 21.22M 16.83M 15.84M 29.77M 2B 30.02M 199M 77.65M 983M 79.64M 77.94M 3.4B
Net Debt -54.72M -63.43M -50.31M -47.35M -88.98M -5.99B -89.73M -596M -232M -2.94B -238M -233M -10.16B -46.87M -54.33M -43.09M -40.56M -76.21M -5.13B -76.85M -511M -199M -2.52B -204M -200M -8.7B
Logo GENFIT
GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).
Employees
188
Date Price Change Volume
12/06/26 9.980 $ -2.16% 100
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
9.480EUR
Average target price
14.00EUR
Spread / Average Target
+47.68%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!